The S1P pathway has been demonstrated to be involved in CCA progression, as reflected by increased tumor growth and associated malignant biliary obstruction in relation to a progressive increase in SPHK1 expression in an orthotopic rat CCA model [212]. The gene discussed is SPHK1; the disease is cholangiocarcinoma.